# Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

> **NCT06929806** · PHASE3 · RECRUITING · sponsor: **Pharmacosmos A/S** · enrollment: 1900 (estimated)

## Conditions studied

- Chronic Heart Failure
- Iron Deficiencies

## Interventions

- **DRUG:** Ferric Derisomaltose

## Key facts

- **NCT ID:** NCT06929806
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 1900 (ESTIMATED)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06929806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06929806, "Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06929806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*